Live recombinant Salmonella typhi vaccines constructed to investigate the role of rpoS in eliciting immunity to a heterologous antigen

PLoS ONE

Volumn 5, Issue 6, 2010, Pages

  Shi, Huoying ^a   Santander, Javier ^a   Brenneman, Karen E ^a   Wanda, Soo Young ^a   Wang, Shifeng ^a   Senechal, Patti ^a   Sun, Wei ^a   Roland, Kenneth L ^a   Curtiss III, Roy ^a  

^a ARIZONA STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL ANTIGEN; MEMBRANE PROTEIN; RECOMBINANT VACCINE; SIGMA FACTOR RPOS; STREPTOCOCCUS ANTIGEN; SURFACE WATER; TYPHOID VACCINE; BACTERIAL PROTEIN; BACTERIAL VACCINE; SIGMA FACTOR; SIGMA FACTOR KATF PROTEIN, BACTERIA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIGEN EXPRESSION; ARTICLE; BACTERIAL GENE; BACTERIAL STRAIN; BACTERIAL SURVIVAL; BACTERIUM MUTANT; BLOOD; CELLULAR IMMUNITY; COMPLEMENT SYSTEM; CONTROLLED STUDY; DRUG SAFETY; FEMALE; HYPOTHESIS; IMMUNIZATION; IMMUNOGENICITY; MALE; MONOCYTE; NEWBORN; NONHUMAN; PLASMID; PNEUMOCOCCAL INFECTION; SALMONELLA TYPHI; SEROTYPE; SEWAGE; TH1 CELL; TH2 CELL; ANIMAL; GENETICS; HUMAN; IMMUNOLOGY; MOUSE;

MUS; SALMONELLA; SALMONELLA ENTERICA SUBSP. ENTERICA SEROVAR TYPHI; SALMONELLA TYPHI; STREPTOCOCCUS PNEUMONIAE;

ANIMALS; ANTIGENS, BACTERIAL; BACTERIAL PROTEINS; BACTERIAL VACCINES; HUMANS; MICE; PLASMIDS; SALMONELLA TYPHI; SIGMA FACTOR; VACCINES, SYNTHETIC;

EID: 77955302589     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0011142     Document Type: Article

References (103)

1. Germanier R, Furer E (1975) Isolation and characterization of Gal E mutant Ty 21a of Salmonella typhi: a candidate strain for a live, oral typhoid vaccine. J Infect Dis 131: 553-558.
2. Wu HY, Nahm MH, Guo Y, Russell MW, Briles DE (1997) Intranasal immunization of mice with PspA (pneumococcal surface protein A) can prevent intranasal carriage, pulmonary infection, and sepsis with Streptococcus pneumoniae. J Infect Dis 175: 839-846.
3. Arulanandam BP, Lynch JM, Briles DE, Hollingshead S, Metzger DW (2001) Intranasal vaccination with pneumococcal surface protein A and interleukin-12 augments antibody mediated opsonization and protective immunity against Streptococcus pneumoniae infection. Infect Immun 69: 6718-6724.
4. Yamamoto M, McDaniel LS, Kawabata K, Briles DE, Jackson RJ, et al. (1997) Oral immunization with PspA elicits protective humoral immunity against Streptococcus pneumoniae infection. Infect Immun 65: 640-644.
5. Nayak AR, Tinge SA, Tart RC, McDaniel LS, Briles DE, et al. (1998) A live recombinant avirulent oral Salmonella vaccine expressing pneumococcal surface protein A induces protective responses against Streptococcus pneumoniae. Infect Immun 66: 3744-3751.
6. Kang HY, Srinivasan J, Curtiss R, III (2002) Immune responses to recombinant pneumococcal PspA antigen delivered by live attenuated Salmonella enterica serovar Typhimurium vaccine. Infect Immun 70: 1739-1749.
7. Germanier R, Furer E (1971) Immunity in experimental salmonellosis. II. Basis for the avirulence and protective capacity of gal E mutants of Salmonella typhimurium. Infect Immun 4: 663-673.
8. Hoiseth SK, Stocker BA (1981) Aromatic-dependent Salmonella typhimurium are non-virulent and effective as live vaccines. Nature 291: 238-239.
9. Curtiss R, III, Kelly SM (1987) Salmonella typhimurium deletion mutants lacking adenylate cyclase and cyclic AMP receptor protein are avirulent and immunogenic. Infect Immun 55: 3035-3043.
10. Galan JE, Curtiss R, III (1989) Virulence and vaccine potential of phoP mutants of Salmonella typhimurium. Microb Pathog 6: 433-443.
11. Miller SI, Kukral AM, Mekalanos JJ (1989) A two-component regulatory system (phoP phoQ) controls Salmonella typhimurium virulence. Proc Natl Acad Sci U S A 86: 5054-5058.
12. Hone DM, Attridge SR, Forrest B, Morona R, Daniels D, et al. (1988) A DgalE via (Vi antigen-negative) mutant of Salmonella typhi Ty2 retains virulence in humans. Infect Immun 56: 1326-1333.
13. Tacket CO, Hone DM, Curtiss R, III, Kelly SM, Losonsky G, et al. (1992) Comparison of the safety and immunogenicity of DaroC DaroD and Dcya Dcrp Salmonella typhi strains in adult volunteers. Infect Immun 60: 536-541.
14. Nardelli-Haefliger D, Kraehenbuhl JP, Curtiss R, III, Schodel F, Potts A, et al. (1996) Oral and rectal immunization of adult female volunteers with a recombinant attenuated Salmonella typhi vaccine strain. Infect Immun 64: 5219-5224.
15. Tacket CO, Kelly SM, Schödel F, Losonsky G, Nataro JP, et al. (1997) Safety and immunogenicity in humans of an attenuated Salmonella typhi vaccine vector strain expressing plasmid-encoded hepatitis B antigens stabilized by the Asdbalanced lethal vector system. Infect Immun 65: 3381-3385.
16. Tacket CO, Sztein MB, Wasserman SS, Losonsky G, Kotloff KL, et al. (2000) Phase 2 clinical trial of attenuated Salmonella enterica serovar typhi oral live vector vaccine CVD 908-htrA in U.S. volunteers. Infect Immun 68: 1196-1201.
17. Hindle Z, Chatfield SN, Phillimore J, Bentley M, Johnson J, et al. (2002) Characterization of Salmonella enterica derivatives harboring defined aroC and Salmonella pathogenicity island 2 type III secretion system (ssaV) mutations by immunization of healthy volunteers. Infect Immun 70: 3457-3467.
18. Hohmann EL, Oletta CA, Miller SI (1996) Evaluation of a phoP/phoQ-deleted, aroA-deleted live oral Salmonella typhi vaccine strain in human volunteers. Vaccine 14: 19-24.
19. Curtiss R, III (2005) Antigen delivery systems: development of live recombinant attenuated bacterial antigen and DNA vaccine delivery vector vaccines. In: Mestecky J, Lamm ME, Strober W, Bienenstock J, McGhee JR, et al., eds. mucosal Immunology, 3rd edition. San Diego: Academic Press. pp 1009-1037.
20. Kotton CN, Hohmann EL (2004) Enteric pathogens as vaccine vectors for foreign antigen delivery. Infect Immun 72: 5535-5547.
21. Fang FC, Libby SJ, Buchmeier NA, Loewen PC, Switala J, et al. (1992) The alternative s factor katF (rpoS) regulates Salmonella virulence. Proc Natl Acad Sci U S A 89: 11978-11982.
22. Chen CY, Buchmeier NA, Libby S, Fang FC, Krause M, et al. (1995) Central regulatory role for the RpoS sigma factor in expression of Salmonella dublin plasmid virulence genes. J Bacteriol 177: 5303-5309.
23. Kowarz L, Coynault C, Robbe-Saule V, Norel F (1994) The Salmonella typhimurium katF (rpoS) gene: cloning, nucleotide sequence, and regulation of spvR and spvABCD virulence plasmid genes. J Bacteriol 176: 6852-6860.
24. Nickerson CA, Curtiss R, III (1997) Role of sigma factor RpoS in initial stages of Salmonella typhimurium infection. Infect Immun 65: 1814-1823.
25. Gulig PA, Curtiss R, III (1987) Plasmid-associated virulence of Salmonella typhimurium. Infect Immun 55: 2891-2901.
26. Coynault C, Robbe-Saule V, Norel F (1996) Virulence and vaccine potential of Salmonella typhimurium mutants deficient in the expression of the RpoS (ss) regulon. Mol Microbiol 22: 149-160.
27. Coynault C, Norel F (1999) Comparison of the abilities of Salmonella typhimurium rpoS, aroA and rpoS aroA strains to elicit humoral immune responses in BALB/c mice and to cause lethal infection in athymic BALB/c mice. Microb Pathog 26: 299-305.
28. Curtiss R, III, Wanda SY, Gunn BM, Zhang X, Tinge SA, et al. (2009) Salmonella enterica serovar Typhimurium strains with regulated delayed attenuation in vivo. Infect Immun 77: 1071-1082.
29. Curtiss R, III, Zhang X, Wanda SY, Kang HY, Konjufca V, et al. (2007) Induction of host immune responses using Salmonella-vectored vaccines. In: KA Brogden FCM, TB Stanton, Q Zhang, L Nolan, MJ Wannemuehler, eds. virulence mechanisms of bacterial pathogens. Washington D.C: 4th ed. ASM Press. pp 297-313.
30. Xin W, Wanda SY, Li Y, Wang S, Mo H, et al. (2008) Analysis of type II secretion of recombinant pneumococcal PspA and PspC in a Salmonella enterica serovar Typhimurium vaccine with regulated delayed antigen synthesis. Infect Immun 76: 3241-3254.
31. Kong W, Wanda SY, Zhang X, Bollen W, Tinge SA, et al. (2008) Regulated programmed lysis of recombinant Salmonella in host tissues to release protective antigens and confer biological containment. Proc Natl Acad Sci U S A 105: 9361-9366.
32. Galyov EE, Wood MW, Rosqvist R, Mullan PB, Watson PR, et al. (1997) A secreted effector protein of Salmonella dublin is translocated into eukaryotic cells and mediates inflammation and fluid secretion in infected ileal mucosa. Mol Microbiol 25: 903-912.
33. Santos RL, Tsolis RM, Zhang S, Ficht TA, Bäumler AJ, et al. (2001) Salmonella induced cell death is not required for enteritis in calves. Infect Immun 69: 4610-4617.
34. Gunn BM, Wanda SY, Burshell D, Wang CH, Curtiss R, III (2010) Construction of recombinant attenuated Salmonella enterica Typhimurium vaccine (RASV) vector strains for safety in newborn and infant mice. Clin Vaccine Immunol: In press.
35. Li Y, Wang S, Xin W, Scarpellini G, Shi Z, et al. (2008) A sopB deletion mutation enhances the immunogenicity and protective efficacy of a heterologous antigen delivered by live attenuated Salmonella enterica vaccines. Infect Immun 76: 5238-5246.
36. Galan JE, Nakayama K, Curtiss R, III (1990) Cloning and characterization of the asd gene of Salmonella typhimurium: use in stable maintenance of recombinant plasmids in Salmonella vaccine strains. Gene 94: 29-35.
37. Bollen WS, Gunn BM, Mo H, Lay MK, Curtiss R, III (2008) Presence of wildtype and attenuated Salmonella enterica strains in brain tissues following inoculation of mice by different routes. Infect Immun 76: 3268-3272.
38. Li Y, Wang S, Scarpellini G, Gunn B, Xin W, et al. (2009) Evaluation of new generation Salmonella enterica serovar Typhimurium vaccines with regulated delayed attenuation to induce immune responses against PspA. Proc Natl Acad Sci U S A 106: 593-598.
39. Shi H, Wang S, Roland K, Gunn BM, Curtiss R, III (2010) Immunogenicity of a live recombinant Salmonella vaccine expressing pspA in neonates and infant mice born from naïve and immunized mothers. Clin Vaccine Immunol: In press.
40. Broome C (1996) Meningococcal and pneumococcal disease vaccines. Progress of vaccine research and development 1996 (document WHO/VRD/ GEN9602). Geneva: World Health Organization. pp 28-32.
41. Park IH, Pritchard DG, Cartee R, Brandao A, Brandileone MC, et al. (2007) Discovery of a new capsular serotype (6C) within serogroup 6 of Streptococcus pneumoniae. J Clin Microbiol 45: 1225-1233.
42. Henrichsen J (1995) Six newly recognized types of Streptococcus pneumoniae. J Clin Microbiol 33: 2759-2762.
43. Obaro SK, Adegbola RA, Banya WA, Greenwood BM (1996) Carriage of pneumococci after pneumococcal vaccination. Lancet 348: 271-272.
44. Mbelle N, Huebner RE, Wasas AD, Kimura A, Chang I, et al. (1999) Immunogenicity and impact on nasopharyngeal carriage of a nonavalent pneumococcal conjugate vaccine. J Infect Dis 180: 1171-1176.
45. Dagan R, Givon-Lavi N, Zamir O, Fraser D (2003) Effect of a nonavalent conjugate vaccine on carriage of antibiotic-resistant Streptococcus pneumoniae in day-care centers. Pediatr Infect Dis J 22: 532-540.
46. Eskola J, Kilpi T, Palmu A, Jokinen J, Haapakoski J, et al. (2001) Efficacy of a pneumococcal conjugate vaccine against acute otitis media. N Engl J Med 344: 403-409.
47. Paton JC, Briles DE (2003) Streptococcus pneumoniae vaccines. In: Ellis RW, Brodeur BR, eds. New Bacterial Vaccines. Georgetown, TX: Landes Bioscience.
48. Santander J, Wanda SY, Nickerson CA, Curtiss R, III (2007) Role of RpoS in fine-tuning the synthesis of Vi capsular polysaccharide in Salmonella enterica serotype Typhi. Infect Immun 75: 1382-1392.
49. Bertani G (1951) Studies on lysogenesis. I. The mode of phage liberation by lysogenic Escherichia coli. J Bacteriol 62: 293-300.
50. Fraser D, Jerrel EA (1953) The amino acid composition of T3 bacteriophage. J Biol Chem 205: 291-295.
51. Romeo T, Preiss J (1989) Genetic regulation of glycogen biosynthesis in Escherichia coli: in vitro effects of cyclic AMP and guanosine 59-diphosphate 39- diphosphate and analysis of in vivo transcripts. J Bacteriol 171: 2773-2782.
52. Neilands JB (1994) Identification and isolation of mutants defective in iron acquisition. Methods Enzymol 235: 352-356.
53. Ross J (1996) Comments on the article ''Persistent confusion of total entropy and chemical system entropy in chemical thermodynamics''(1996). Proc Natl Acad Sci U S A 93: 7452-7453.
54. Sambrook J, DW R (2001) Molecular Cloning: A Laboratory Manual (Cold Spring Harbor Lab Press, Plainview, NY). 3rd version.
55. Miller VL, Mekalanos JJ (1988) A novel suicide vector and its use in construction of insertion mutations: osmoregulation of outer membrane proteins and virulence determinants in Vibrio cholerae requires toxR. J Bacteriol 170: 2575-2583.
56. Ried JL, Collmer A (1987) An nptI-sacB-sacR cartridge for constructing directed, unmarked mutations in gram-negative bacteria by marker exchange-eviction mutagenesis. Gene 57: 239-246.
57. Sun W, Wang S, Curtiss R, III (2008) Highly efficient method for introducing successive multiple scarless gene deletions and markerless gene insertions into the Yersinia pestis chromosome. Appl Environ Microbiol 74: 4241-4245.
58. Kang HY, Dozois CM, Tinge SA, Lee TH, Curtiss R, III (2002) Transductionmediated transfer of unmarked deletion and point mutations through use of counterselectable suicide vectors. J Bacteriol 184: 307-312.
59. Old DC, Corneil I, Gibson LF, Thomson AD, Duguid JP (1968) Fimbriation, pellicle formation and the amount of growth of salmonellas in broth. J Gen Microbiol 51: 1-16.
60. Korhonen TK, Lounatmaa K, Ranta H, Kuusi N (1980) Characterization of type I pili of Salmonella typhimurium LT2. J Bacteriol 144: 800-805.
61. Hitchcock PJ, Brown TM (1983) Morphological heterogeneity among Salmonella lipopolysaccharide chemotypes in silver-stained polyacrylamide gels. J Bacteriol 154: 269-277.
62. Kado CI, Liu ST (1981) Rapid procedure for detection and isolation of large and small plasmids. J Bacteriol 145: 1365-1373.
63. Mulvey MR, Switala J, Borys A, Loewen PC (1990) Regulation of transcription of katE and katF in Escherichia coli. J Bacteriol 172: 6713-6720.
64. Buchmeier NA, Libby SJ, Xu Y, Loewen PC, Switala J, et al. (1995) DNA repair is more important than catalase for Salmonella virulence in mice. J Clin Invest 95: 1047-1053.
65. Hengge-Aronis R, Fischer D (1992) Identification and molecular analysis of glgS, a novel growth-phase-regulated and rpoS-dependent gene involved in glycogen synthesis in Escherichia coli. Mol Microbiol 6: 1877-1886.
66. Konjufca V, Wanda SY, Jenkins MC, Curtiss R, III (2006) A recombinant attenuated Salmonella enterica serovar Typhimurium vaccine encoding Eimeria acervulina antigen offers protection against E. acervulina challenge. Infect Immun 74: 6785-6796.
67. Witholt B, Boekhout M, Brock M, Kingma J, Heerikhuizen HV, et al. (1976) An efficient and reproducible procedure for the formation of spheroplasts from variously grown Escherichia coli. Anal Biochem 74: 160-170.
68. Ellner P, Stoessel C (1966) The role of temperature and anticoagulant on the in vitro survival of bacterial in blood. J Infect Dis. pp 238-242.
69. Coligan JE, Kruisbeek AM, Margulies DH, Shevach EM, Strober W (1994) Current Protocols in Immunology (John Wiley, New York). Section 7.6.
70. Schwan WR, Huang XZ, Hu L, Kopecko DJ (2000) Differential bacterial survival, replication, and apoptosis-inducing ability of Salmonella serovars within human and murine macrophages. Infect Immun 68: 1005-1013.
71. Roland KL, Cloninger C, Kochi SK, Thomas LJ, Tinge SA, et al. (2007) Construction and preclinical evaluation of recombinant Peru-15 expressing high levels of the cholera toxin B subunit as a vaccine against enterotoxigenic Escherichia coli. Vaccine 25: 8574-8584.
72. Curtiss R, III (1965) Chromosomal aberrations associated with mutations to bacteriophage resistance in Escherichia coli. J Bacteriol 89: 28-40.
73. Sedgwick JD, Holt PG (1983) A solid-phase immunoenzymatic technique for the enumeration of specific antibody-secreting cells. J Immunol Methods 57: 301-309.
74. Collinson SK, Clouthier SC, Doran JL, Banser PA, Kay WW (1996) Salmonella enteritidis agfBAC operon encoding thin, aggregative fimbriae. J Bacteriol 178: 662-667.
75. White AP, Gibson DL, Kim W, Kay WW, Surette MG (2006) Thin aggregative fimbriae and cellulose enhance long-term survival and persistence of Salmonella. J Bacteriol 188: 3219-3227.
76. Stevenson G, Andrianopoulos K, Hobbs M, Reeves PR (1996) Organization of the Escherichia coli K-12 gene cluster responsible for production of the extracellular polysaccharide colanic acid. J Bacteriol 178: 4885-4893.
77. Andrianopoulos K, Wang L, Reeves PR (1998) Identification of the fucose synthetase gene in the colanic acid gene cluster of Escherichia coli K-12. J Bacteriol 180: 998-1001.
78. Ledeboer NA, Jones BD (2005) Exopolysaccharide sugars contribute to biofilm formation by Salmonella enterica serovar typhimurium on HEp-2 cells and chicken intestinal epithelium. J Bacteriol 187: 3214-3226.
79. Raffatellu M, Chessa D, Wilson RP, Dusold R, Rubino S, et al. (2005) The Vi capsular antigen of Salmonella enterica serotype Typhi reduces Toll-like receptordependent interleukin-8 expression in the intestinal mucosa. Infect Immun 73: 3367-3374.
80. Arricau N, Hermant D, Waxin H, Ecobichon C, Duffey PS, et al. (1998) The RcsB-RcsC regulatory system of Salmonella typhi differentially modulates the expression of invasion proteins, flagellin and Vi antigen in response to osmolarity. Mol Microbiol 29: 835-850.
81. Winter SE, Winter MG, Thiennimitr P, Gerriets VA, Nuccio SP, et al. (2009) The TviA auxiliary protein renders the Salmonella enterica serotype Typhi RcsB regulon responsive to changes in osmolarity. Mol Microbiol 74: 175-193.
82. Santander J, Roland KL, Curtiss R, III (2008) Regulation of Vi capsular polysaccharide synthesis in Salmonella enterica serotype Typhi. J Infect Dev Ctries 2: 412-420.
83. Link C, Ebensen T, Standner L, Dejosez M, Reinhard E, et al. (2006) An SopB-mediated immune escape mechanism of Salmonella enterica can be subverted to optimize the performance of live attenuated vaccine carrier strains. Microbes Infect 8: 2262-2269.
84. Boron WF (2003) A Cellular and Molecular Approach. Medical Physiology Elsevier/Saunders. pp 1300.
85. Curtiss R, III (2002) Bacterial infectious disease control by vaccine development. J Clin Invest 110: 1061-1066.
86. Rubin FA, McWhirter PD, Burr D, Punjabi NH, Lane E, et al. (1990) Rapid diagnosis of typhoid fever through identification of Salmonella typhi within 18 hours of specimen acquisition by culture of the mononuclear cell-platelet fraction of blood. J Clin Microbiol 28: 825-827.
87. Sizemore DR, Elsinghorst EA, Eck LC, Branstrom AA, Hoover DL, et al. (1997) Interaction of Salmonella typhi strains with cultured human monocytederived macrophages. Infect Immun 65: 309-312.
88. Looney RJ, Steigbigel RT (1986) Role of the Vi antigen of Salmonella typhi in resistance to host defense in vitro. J Lab Clin Med 108: 506-516.
89. Briles DE, King JD, Gray MA, McDaniel LS, Swiatlo E, et al. (1996) PspA, a protection-eliciting pneumococcal protein: immunogenicity of isolated native PspA in mice. Vaccine 14: 858-867.
90. Pasetti MF, Levine MM, Sztein MB (2003) Animal models paving the way for clinical trials of attenuated Salmonella enterica serovar Typhi live oral vaccines and live vectors. Vaccine 21: 401-418.
91. Chatfield SN, Fairweather N, Charles I, Pickard D, Levine M, et al. (1992) Construction of a genetically defined Salmonella typhi Ty2 aroA, aroC mutant for the engineering of a candidate oral typhoid-tetanus vaccine. Vaccine 10: 53-60.
92. Baker SJ, Daniels C, Morona R (1997) PhoP/Q regulated genes in Salmonella typhi identification of melittin sensitive mutants. Microb Pathog 22: 165-179.
93. Angelakopoulos H, Hohmann EL (2000) Pilot study of phoP/phoQ-deleted Salmonella enterica serovar Typhimurium expressing Helicobacter pylori urease in adult volunteers. Infect Immun 68: 2135-2141.
94. Bravo D, Silva C, Carter JA, Hoare A, Alvarez SA, et al. (2008) Growth-phase regulation of lipopolysaccharide O-antigen chain length influences serum resistance in serovars of Salmonella. J Med Microbiol 57: 938-946.
95. Capozzo AV, Cuberos L, Levine MM, Pasetti MF (2004) Mucosally delivered Salmonella live vector vaccines elicit potent immune responses against a foreign antigen in neonatal mice born to naive and immune mothers. Infect Immun 72: 4637-4646.
96. Roland K, Curtiss R, III, Sizemore D (1999) Construction and evaluation of a Dcya Dcrp Salmonella typhimurium strain expressing avian pathogenic Escherichia coli O78 LPS as a vaccine to prevent airsacculitis in chickens. Avian Dis 43: 429-441.
97. Hassan JO, Curtiss R, III (1996) Effect of vaccination of hens with an avirulent strain of Salmonella typhimurium on immunity of progeny challenged with wild- Type Salmonella strains. Infect Immun 64: 938-944.
98. Baek CH, Wang S, Roland KL, Curtiss R, III (2009) Leucine-responsive regulatory protein (Lrp) acts as a virulence repressor in Salmonella enterica serovar Typhimurium. J Bacteriol 191: 1278-1292.
99. Felix A, Pitt RM (1951) The pathogenic and immunogenic activities of Salmonella typhi: in relation to its antigenic constituents. J Hyg 49: 92-110.
100. Hone DM, Harris AM, Chatfield S, Dougan G, Levine MM (1991) Construction of genetically defined double aro mutants of Salmonella typhi. Vaccine 9: 810-816.
101. Edwards RA, Keller LH, Schifferli DM (1998) Improved allelic exchange vectors and their use to analyze 987P fimbria gene expression. Gene 207: 149-157.
102. Dozois CM, Dho-Moulin M, Brée A, Fairbrother JM, Desautels C, et al. (2000) Relationship between the Tsh autotransporter and pathogenicity of avian Escherichia coli and localization and analysis of the tsh genetic region. Infect Immun 68: 4145-4154.
103. Curtiss R, III (2003) Regulation of attenuation of live vaccines to enhance cross protective immunity. International patent WO 03/096812.